🟢 Dolmas (stuffed grape leaves) VS 🟡 Guava
The oxalate gap between these two is hard to ignore. Guava at 83 mg per serving vs Dolmas (stuffed grape leaves) at 2 mg — 41x more. One is a daily option, the other requires careful consideration.
⚖️ Head-to-Head Comparison
Per 100 g: 2 mg oxalate
Sodium: — | Calcium: — | Protein: —
Per 100 g: 70 mg oxalate
Sodium: 4 mg/100g | Calcium: 7 mg/100g | Protein: 0.3 g/100g
🏆 The Verdict: Choose Dolmas (stuffed grape leaves)
At 2 mg oxalate per serving (rated Safe), Dolmas (stuffed grape leaves) is the clear winner over Guava (83 mg, Caution). The 41x difference comes from Harvard's 2024 lab measurements — this isn't an estimate or guess. Build your meals around Dolmas (stuffed grape leaves) and use Guava sparingly, if at all.
🔍 Key Takeaways
❓ Frequently Asked Questions
Which is better for kidney stones — Guava or Dolmas (stuffed grape leaves)?
The numbers leave no doubt: Dolmas (stuffed grape leaves) (2 mg oxalate/serving, Safe) beats Guava (83 mg, Caution) by a factor of 41x. For kidney stone patients, Dolmas (stuffed grape leaves) is the pick. Guava is a food to approach with portion awareness.
Can I eat Guava and Dolmas (stuffed grape leaves) together?
You can, but be aware of the math. Together they'd total about 85 mg oxalate — which is in Caution territory. If both are in one meal, the oxalate load adds up. Better strategy: make Dolmas (stuffed grape leaves) the main component and use Guava sparingly.
How should I prepare Guava vs Dolmas (stuffed grape leaves) differently?
For Guava, boiling and draining cuts oxalate by 30-50%. Steaming preserves more. For Dolmas (stuffed grape leaves), preparation method matters less — it's already low-oxalate. If you're cooking both, boil Guava separately and discard the water.
What are good substitutes if I want to avoid Guava?
Dolmas (stuffed grape leaves) is the #1 substitute in the same category. Beyond that, look for foods with the 🟢 Safe rating in the Fruits category — they're all under 25 mg oxalate per serving and verified by Harvard (2024).